Know Cancer

or
forgot password
  • cancer clinical trials in decatur, IL

  • Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Lung Cancer
    Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Esophageal Cancer, Gastric Cancer
    Oxaliplatin in Treating Patients With Metastatic Bladder Cancer
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Lung Cancer
    Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Head and Neck Cancer
    O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Sarcoma
    Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Lung Cancer
    Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Metastatic Cancer
    O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Melanoma (Skin)
    SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Colorectal Cancer
    SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Prostate Cancer
    SU5416 in Treating Patients With Malignant Mesothelioma
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Malignant Mesothelioma
    ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Head and Neck Cancer
    Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Colorectal Cancer
    S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System
    CCI-779 in Treating Patients With Metastatic Melanoma
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Melanoma (Skin)
    BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Colorectal Cancer
    PS-341 in Treating Patients With Metastatic Kidney Cancer
    Cancer Care Specialists of Central Illinois, S.C.
    Decatur, Illinois 62526
    Kidney Cancer
    Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Colorectal Cancer
    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Prostate Cancer
    Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Kidney Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Lung Cancer
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Head and Neck Cancer
    Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Leukemia, Myelodysplastic Syndromes
    S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Leukemia
    STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
    Decatur Memorial Hospital
    Decatur, Illinois 62526
    Neoplasms, Diarrhea
    Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Pancreatic Cancer
    Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Head and Neck Cancer
    A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
    ImClone Investigational Site
    Decatur, Illinois 62526
    Colorectal Neoplasms
    TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
    Decatur Memorial Hospital

    Trial Locations
    Decatur Memorial Hospital
    Cancer Care Specialists of Central IL
    Ovarian Neoplasms
    Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer
    ImClone Investigational Site
    Decatur, Illinois 62526
    Non-Small-Cell Lung Cancer
    Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Lung Cancer
    Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Decatur Memorial Hospital
    Decatur, Illinois 62526
    Prostate Cancer, Hormone Refractory Prostate Cancer
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Pancreatic Cancer
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Multiple Myeloma, Plasma Cell Neoplasm
    Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Breast Cancer
    Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Cancer Care Specialists of Central IL

    Trial Locations
    Cancer Care Specialists of Central IL
    Decatur Memorial Hospital/Clinical Research
    Non Small Cell Lung Carcinoma
    MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
    Decatur Memorial Hospital

    Trial Locations
    Decatur Memorial Hospital
    Cancer Care Specialists of Central IL
    Melanoma, Metastases
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Mesothelioma
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Lung Cancer
    Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Head and Neck Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Melanoma (Skin)
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Breast Cancer
    Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
    Cancer Care Specialists of Central Illinois
    Decatur, Illinois 62256
    Lung Cancer, Non Small Cell Lung Carcinoma
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Lymphoma
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Sarcoma
    S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Breast Cancer
    S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Malignant Mesothelioma
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Cancer Institute of Central Illinois/Decatur Memorial Hospital
    Decatur, Illinois 62526
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Head and Neck Cancer
    A Safety Study of Lintuzumab in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Cancer Care Specialists of Central Illinois
    Decatur, Illinois 62256
    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia
    S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Prostate Cancer
    CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
    Decatur Memorial Hospital
    Decatur, Illinois 62526
    B-cell Chronic Lymphocytic Leukemia, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Malignant Neoplasm, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Kidney Cancer, Metastatic Cancer
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Decatur Memorial Hospital
    Decatur, Illinois 62526
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
    Decatur Memorial Hospital
    Decatur, Illinois 62526
    Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
    Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Colorectal Cancer
    Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Carcinoma of Unknown Primary, Pain
    Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers
    Decatur Memorial Hospital Cancer Care Institute
    Decatur, Illinois 62526
    Colorectal Cancer, Fatigue, Long-term Effects Secondary to Cancer Therapy in Adults, Pain, Psychosocial Effects of Cancer and Its Treatment